Sirio Pharma Co., Ltd. (SHE:300791)

Market Cap	5.99B
Revenue (ttm)	4.21B
Net Income (ttm)	330.67M
Shares Out	235.60M
EPS (ttm)	1.42
PE Ratio	17.92
Forward PE	15.26
Dividend	0.85 (3.33%)
Ex-Dividend Date	Jun 21, 2024

Volume	1,311,730
Average Volume	3,092,273
Open	25.40
Previous Close	25.41
Day's Range	24.85 - 25.86
52-Week Range	21.22 - 35.48
Beta	0.87
RSI	49.36
Earnings Date	Apr 18, 2025

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is headquartered in Shantou, China.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1993
• Employees: 2,610
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300791

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.